Pricing Log in Create free account
Saturday 17 October 2026 Export JNJ’s income statement to Excel — free account

Johnson & Johnson

JNJ Healthcare Drug Manufacturers General

Johnson & Johnson’s revenue for fiscal 2025 (year ended December 2025) was $94.2 billion, up 6.05% from fiscal 2024. In the quarter to September 2026, revenue grew 5.86%, EPS was flat, free cash flow grew 154.8% and total debt fell 4.82%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for three, operating cash flow growth for three; insiders bought in the last twelve months.

255.55 2.27 +0.90%
Market cap
$610.4B
P/E
29.6×
Fwd P/E
24.9×
Dividend yield
2.07%
F-score
3/9
Altman Z
4.78
Beneish M
−2.26
Dividend safety
78/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Johnson & Johnson (JNJ) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Johnson & Johnson (JNJ) trades at a P/S ratio of 6.2×. Over the past ten years it has ranged from 3.5× (August 2015) to 6.8× (September 2026); the current reading is higher than 97% of that period. That is above the Drug Manufacturers General industry median of 3.4× and above the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 5.3× 34.94%
FY2024 3.9× (17.64%)
FY2023 4.8× (18.62%)
FY2022 5.8× 2.26%
FY2021 5.7× 13.98%
FY2020 5.0× 6.71%
FY2019 4.7× 10.85%
FY2018 4.2× (13.48%)
FY2017 4.9× 11.15%
FY2016 4.4× 8.56%

Quarterly newest first

Period P/S ratio Change
Sep 2026 6.4× 2.76%
Jun 2026 6.2× 2.18%
Mar 2026 6.1× 15.52%
Dec 2025 5.3× 9.15%
43 more quarters

Against its own ten years

Low 3.5× High 6.8×
Ten-year median 4.7×
Current reading's percentile 97

P/S ratio against peers

Company P/S ratio
PFE Pfizer Inc. compare 2.6×
AZN AstraZeneca PLC compare 4.2×
NVS Novartis AG compare 5.1×
MRK Merck & Co., Inc. compare 5.4×
AMGN Amgen Inc. compare 6.1×
JNJ Johnson & Johnson 6.2×
GILD Gilead Sciences, Inc. compare 6.4×
ABBV AbbVie Inc. compare 7.8×
LLY Eli Lilly and Company compare 14.1×
Drug Manufacturers General industry median 3.4×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on JNJ